Association of genetic risk factors with cognitive decline: the PATH through life project

被引:43
|
作者
Andrews, Shea J. [1 ]
Das, Debjani [1 ]
Cherbuin, Nicolas [2 ]
Anstey, Kaarin J. [2 ]
Easteal, Simon [1 ]
机构
[1] Australian Natl Univ, John Curtin Sch Med Res, Dept Genome Sci, Canberra, ACT 2601, Australia
[2] Australian Natl Univ, Res Sch Populat Hlth, Ctr Res Ageing Hlth & Wellbeing, Canberra, ACT, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
Alzheimer's disease; Cognitive decline; SNPs; Genetic risk scores; Population-based study; GENOME-WIDE ASSOCIATION; ALZHEIMER-DISEASE; AGE; GENOTYPE; NEUROPATHOLOGY; INTELLIGENCE; ABILITY; PICALM; BIN1; CLU;
D O I
10.1016/j.neurobiolaging.2016.02.016
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
We examined the association of 28 single nucleotide polymorphisms (SNPs), previously associated with dementia or cognitive performance, with tests assessing episodic memory, working memory, vocabulary, and perceptual speed in 1689 nondemented older Australians of European ancestry. In addition to testing each variant individually, we assessed the collective association of the 12-risk SNPs for late-onset Alzheimer's disease using weighted and unweighted genetic risk scores. Significant associations with cognitive performance were observed for APOE epsilon 4 allele, ABCA7-rs3764650, CR1-rs3818361, MS4A4E-rs6109332, BDNF-rs6265, COMT-rs4680, CTNNBL-rs6125962, FRMD4A-rs17314229, FRMD4A-rs17314229, intergenic SNP chrX-rs12007229, PDE7A-rs10808746, SORL1-rs668387, and ZNF224-rs3746319. In addition, the weighted genetic risk score was associated with worse performance on episodic memory. The identification of genetic risk factors, that act individually or collectively, may help in screening for people with elevated risk of cognitive decline and for understanding the biological pathways that underlie cognitive decline. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:150 / 158
页数:9
相关论文
共 50 条
  • [1] Cancer And Cognitive Decline: The PATH Through Life Project
    Kim, Sarang
    [J]. GERONTOLOGIST, 2015, 55
  • [2] Cancer and Cognitive Function: The PATH Through Life Project
    Kim, Sarang
    Cherbuin, Nicolas
    Anstey, Kaarin J.
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2017, 72 (09): : 1226 - 1232
  • [3] Dietary mineral intake and risk of mild cognitive impairment: the PATH through life project
    Cherbuin, Nicolas
    Kumar, Rajeev
    Sachdev, Perminder S.
    Anstey, Kaarin J.
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2014, 6
  • [4] Late Onset Alzheimer's Disease Risk Variants in Cognitive Decline: The PATH Through Life Study
    Andrews, Shea J.
    Das, Debjani
    Anstey, Kaarin J.
    Easteal, Simon
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2017, 57 (02) : 423 - 436
  • [5] Association of Anxiety Awareness with Risk Factors of Cognitive Decline in MCI
    Gigi, Ariela
    Papirovitz, Merav
    [J]. BRAIN SCIENCES, 2021, 11 (02) : 1 - 7
  • [6] Self-Reported History of Chemotherapy and Cognitive Decline in Adults Aged 60 and Older: The PATH Through Life Project
    Anstey, Kaarin J.
    Sargent-Cox, Kerry
    Cherbuin, Nicolas
    Sachdev, Perminder S.
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2015, 70 (06): : 729 - 735
  • [7] Midlife risk factors for late-life cognitive decline
    Carroll, Sarah
    Turkheimer, Eric
    [J]. DEVELOPMENTAL REVIEW, 2018, 48 : 201 - 222
  • [8] PSYCHOLOGICAL RISK FACTORS FOR LATE-LIFE COGNITIVE AND FUNCTIONAL DECLINE
    不详
    [J]. GERONTOLOGIST, 2013, 53 : 537 - 537
  • [9] Risk Factors of Transition from Normal Cognition to Mild Cognitive Disorder: The PATH through Life Study
    Cherbuin, Nicolas
    Reglade-Meslin, Chantal
    Kumar, Rajeev
    Jacomb, Patricia
    Easteal, Simon
    Christensen, Helen
    Sachdev, Perminder
    Anstey, Kaarin J.
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2009, 28 (01) : 47 - 55
  • [10] Risk factors and prevention of cognitive decline
    Yaffe, K
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (06): : 778 - 778